A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)

Clinical trial NCT04787328 · UNKNOWN

Trial details

NCT number: NCT04787328
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Medullary Thyroid Carcinoma

Start date: 2021-07-13
Primary completion: 2023-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.